EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Josef S. Smolen*, Robert Landewe, Ferdinand C. Breedveld, Maxime Dougados, Paul Emery, Cecile Gaujoux-Viala, Simone Gorter, Rachel Knevel, Jackie Nam, Monika Schoels, Daniel Aletaha, Maya Buch, Laure Gossec, Tom W J Huizinga, Johannes W J Bijlsma, Gerd Burmester, Bernard Combe, Maurizio Cutolo, Cem Gabay, Juan Gomez-ReinoMarios Kouloumas, Tore K. Kvien, Emilio Martin-Mola, Iain B. McInnes, Karel Pavelka, Piet van Riel, Marieke Scholte-Voshaar, David L. Scott, Tuulikki Sokka, Guido Valesini, Ronald F. van Vollenhoven, Kevin L. Winthrop, John Q. Wong, Angela Zink, Desiree van der Heijde

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs'. Together they form a unique fingerprint.

Keyphrases

INIS

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology